Tripletail Wealth Management »

Ligand Pharmaceuticals In shares owned by Tripletail Wealth Management

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Tripletail Wealth Management from 13F filings

Historical chart of Tripletail Wealth Management investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Tripletail Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Tripletail Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $129k 710 181.41

More positions owned by Tripletail Wealth Management

John Bean Technologies Corporation (JBTM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Pacer Fds Tr Metaurus Cap 400 (QDPL)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Arista Networks Com Shs (ANET)
Pacer Fds Tr Us Lrg Cp Cash (COWG)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Tripletail Wealth Management

Top funds holding Ligand Pharmaceuticals In

Tudor Investment Corporation
BlackRock
Vanguard Group
Henderson Group
Macquarie Group
State Street Corporation
Congress Asset Management
Chicago Capital
Stephens Investment Management Group
Massachusetts Financial Services
Dimensional Fund Advisors
Geode Capital Management
FMR
Loomis, Sayles and
Invesco

View all funds holding Ligand Pharmaceuticals In